Elicio Therapeutics, Inc. (ELTX) Ownership
ELTX ownership summary
as of October 18, 2026- Institutions
- 20.4% of shares outstanding
- Insiders
- 26.17% of shares outstanding
- Shares outstanding
- 27.1M
- Float
- 19.2M shares available to trade
- Short interest
- 9.70% 1.6M shares short
- Days to cover
- 4.07 short interest down 6.8% vs prior month
- Institutions 20.43%
- Insiders 26.17%
- Other investors 53.40%
ELTX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Shah Capital Management | 4.76% | 1.2M | $1.9M | +1.2M (0.0%) | September 30, 2026 |
| 2 | Knoll Capital Management LP | 4.61% | 1.2M | $1.9M | +581,042 (+92.1%) | June 30, 2026 |
| 3 | BlackRock Inc | 2.91% | 766K | $1.2M | +715,408 (+1,413.9%) | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 2.18% | 572K | $892,556 | +53,513 (+10.3%) | June 30, 2026 |
| 5 | Geode Capital Management, LLC | 1.18% | 311K | $485,712 | +176,190 (+130.4%) | June 30, 2026 |
| 6 | State Street Corp | 0.68% | 179K | $279,895 | +128,800 (+254.4%) | June 30, 2026 |
| 7 | Northern Trust Corp | 0.50% | 130K | $203,053 | +70,428 (+117.9%) | June 30, 2026 |
| 8 | Ikarian Capital, LLC | 0.38% | 100K | $156,000 | +100,000 (0.0%) | June 30, 2026 |
| 9 | Vanguard Portfolio Management, LLC | 0.34% | 89K | $138,692 | +88,905 (0.0%) | June 30, 2026 |
| 10 | Vanguard Fiduciary Trust Co | 0.34% | 88K | $137,377 | +18,873 (+27.3%) | June 30, 2026 |
| 11 | AllianceBernstein L.P. | 0.31% | 81K | $126,797 | +81,280 (0.0%) | June 30, 2026 |
| 12 | 683 Capital Management LLC | 0.21% | 56K | $88,050 | — | March 31, 2026 |
| 13 | UBS Group AG | 0.15% | 40K | $63,054 | +6,650 (+19.7%) | June 30, 2026 |
| 14 | Charles Schwab Investment Management Inc | 0.12% | 32K | $49,461 | +31,706 (0.0%) | June 30, 2026 |
| 15 | BOOTHBAY FUND MANAGEMENT, LLC | 0.12% | 31K | $47,876 | +30,690 (0.0%) | June 30, 2026 |
| 16 | Morgan Stanley - Brokerage Accounts | 0.10% | 26K | $39,852 | −6,858 (−21.2%) | June 30, 2026 |
| 17 | LEONTEQ SECURITIES AG | 0.08% | 20K | $31,200 | +20,000 (0.0%) | June 30, 2026 |
| 18 | Nuveen, LLC | 0.07% | 18K | $27,905 | +17,888 (0.0%) | June 30, 2026 |
| 19 | Citigroup Inc | 0.07% | 18K | $27,653 | +17,726 (0.0%) | June 30, 2026 |
| 20 | Bank of New York Mellon Corp | 0.06% | 16K | $24,779 | +15,884 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 18 holders added 3.4M shares and 1 cut 6,858.
ELTX top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 1.58% | 415K | $648,026 | — | August 31, 2026 |
| 2 | iShares Russell 2000 ETF | 1.22% | 320K | $499,788 | −3,712 (−1.1%) | September 30, 2026 |
| 3 | Fidelity Small Cap Index | 0.53% | 140K | $217,980 | −172 (−0.1%) | July 31, 2026 |
| 4 | iShares Russell 2000 Growth ETF | 0.47% | 123K | $191,537 | −155 (−0.1%) | September 30, 2026 |
| 5 | Abante Quant Value FI | 0.46% | 120K | $187,169 | +57,894 (+93.2%) | August 31, 2026 |
| 6 | Vifag 2002 SICAV | 0.45% | 119K | $186,294 | +30,000 (+33.5%) | July 31, 2026 |
| 7 | Fidelity Extended Market Index | 0.30% | 79K | $123,111 | +16,576 (+26.6%) | August 31, 2026 |
| 8 | Vanguard Russell 2000 ETF | 0.29% | 76K | $118,048 | +1,440 (+1.9%) | August 31, 2026 |
| 9 | Lago Erie SICAV | 0.27% | 70K | $108,763 | — | July 31, 2026 |
| 10 | iShares Micro-Cap ETF | 0.19% | 50K | $78,757 | −348 (−0.7%) | September 30, 2026 |
| 11 | EQ/AB Small Cap Growth IB | 0.15% | 41K | $63,398 | — | August 31, 2026 |
| 12 | EQ/Small Company Index IB | 0.15% | 41K | $63,398 | — | August 31, 2026 |
| 13 | Schwab Small Cap Index | 0.12% | 32K | $49,461 | — | August 31, 2026 |
| 14 | iShares Russell 2000 Small-Cap Idx Instl | 0.11% | 29K | $45,917 | — | August 31, 2026 |
| 15 | Fidelity Total Market Index | 0.08% | 21K | $33,211 | — | August 31, 2026 |
| 16 | Fidelity Series Total Market Index | 0.07% | 18K | $28,415 | — | August 31, 2026 |
| 17 | Nuveen Small Cap Blend Idx R6 | 0.07% | 18K | $27,905 | — | August 31, 2026 |
| 18 | EQ/2000 Managed Volatility IB | 0.06% | 16K | $25,660 | — | August 31, 2026 |
| 19 | Fidelity Small Cap Growth Index | 0.06% | 16K | $25,074 | +3,777 (+30.7%) | July 31, 2026 |
| 20 | Vanguard Russell 2000 Growth ETF | 0.05% | 14K | $21,955 | +68 (+0.5%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ELTX insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-12-22 | Yekaterina Chudnovsky | Buy | $5.81 | 1,213,000 | $7.0M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ELTX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ELTX
Institutional investors own 20.4% of Elicio Therapeutics's shares and insiders 26.17%. The largest holder is Shah Capital Management with 4.76% of the shares (1.2M), as of September 30, 2026. Among the top 20 institutions, 18 added shares and 1 reduced their stake in the latest filings. Short interest is 9.70% of the float, or 4.07 days of average trading volume. The share count rose 419.4% since 2019.
Related: ELTX analyst forecast, ELTX key metrics. See the ELTX stock overview for the latest quote and news.
ELTX ownership FAQ
Who owns the most Elicio Therapeutics stock?
The largest shareholders of Elicio Therapeutics are Shah Capital Management (4.76%), Knoll Capital Management LP (4.61%), BlackRock Inc (2.91%), Vanguard Capital Management, LLC (2.18%), Geode Capital Management, LLC (1.18%).
What percentage of Elicio Therapeutics is owned by institutions?
Institutions hold 20.4% of Elicio Therapeutics's shares outstanding; insiders hold 26.17%.
Which funds own Elicio Therapeutics?
The largest fund holders of Elicio Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (1.58%), iShares Russell 2000 ETF (1.22%), Fidelity Small Cap Index (0.53%), iShares Russell 2000 Growth ETF (0.47%), Abante Quant Value FI (0.46%).
What is Elicio Therapeutics's short interest?
1.6M shares of Elicio Therapeutics were sold short, 9.70% of the float; at the average daily volume it would take 4.07 days to cover.
Are insiders buying or selling Elicio Therapeutics?
Of the latest 1 reported insider transactions in Elicio Therapeutics (since December 22, 2023), 1 were purchases and 0 were sales.
How many shares of Elicio Therapeutics are outstanding?
Elicio Therapeutics has 27.1M shares outstanding, of which 19.2M are in the public float.